Your Location:
Home >
Browse articles >
Material Basis and Molecular Mechanism of Linggui Qihua Prescription Against Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction
Material Basis and Molecular Mechanism of Linggui Qihua Prescription Against Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 20, Pages: 20-29(2023)
DOI: 10.13422/j.cnki.syfjx.20231038
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 6 )
References
Publication Info
Metrics
444
Views
228
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Protective Effects and Molecular Mechanisms of Sini Tang in Treating Ponatinib-induced Heart Failure in Mice
Effect of Kangxian Yixin Prescription on Cardiac Function and Myocardial Fibroblasts in Dilated Cardiomyopathy Rats
Fangji Fulingtang Attenuates Myocardial Fibrosis by Regulating Mitochondrial Function Through AMPK/PGC-1α/MFN2-PKM2 Signaling Pathway
Molecular Mechanism Analysis of Dengzhan Shengmai Capsules Against Myocardial Fibrosis After Myocardial Infarction Based on Network Robustness Algorithm
Action Mechanism of Betulinic Acid in Inhibiting Ferroptosis and Improving Non-alcoholic Fatty Liver Disease Based on Bioinformatics and Experimental Validation
Related Author
FENG Xi
CHENG Yanfen
WANG Pei
LI Jingjing
LI Sha
ZHOU Juehan
LONG Ying
LIU Shengjun
Related Institution
Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine
School of Preclinical Medicine, Chengdu University
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University
The Second Affiliated Hospital of Henan University of Chinese Medicine
Henan University of Chinese Medicine


